Effects of pregnancy and breastfeeding on the multiple sclerosis disease course

Clinical Immunology

Volumn 149, Issue 2, 2013, Pages 244-250

  Langer Gould, Annette ^a,b   Beaber, Brandon E ^b  

^a KAISER PERMANENTE   (United States)

^b Southern California Permanente Medical Group   (United States)

Author keywords

Breastfeeding; Multiple sclerosis; Pregnancy

Indexed keywords

ALCOHOL;

AMENORRHEA; ARTICLE; COMPREHENSION; DIET; DISEASE COURSE; EPIDURAL ANESTHESIA; FAMILY PLANNING; HUMAN; IMMUNOMODULATION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROPROTECTION; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RELAPSE; RISK FACTOR; SLEEP DEPRIVATION; SMOKING; STRESS; VITAMIN DEFICIENCY;

EID: 84885961007     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.01.008     Document Type: Review

References (60)

1. Hellwig K., Haghikia A., Rockhoff M., Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther. Adv. Neurol. Disord. 2012, 5:247-253.
2. Millar J.H., Allison R.S., Cheeseman E.A., Merrett J.D. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959, 82:417-426.
3. Ghezzi A., Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis?. Eur. Neurol. 1981, 20:115-117.
4. Poser S., Poser W. Multiple sclerosis and gestation. Neurology 1983, 33:1422-1427.
5. Nelson L.M., Franklin G.M., Jones M.C. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 1988, 259:3441-3443.
6. Hellwig K., Kleiter I., Gold R. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 2012, 78:371. (author reply).
7. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 1998, 339:285-291.
8. Langer-Gould A., Huang S.M., Gupta R., et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch. Neurol. 2009, 66:958-963.
9. Portaccio E., Ghezzi A., Hakiki B., et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011, 77:145-150.
10. Keyhanian K., Davoudi V., Etemadifar M., Amin M. Better prognosis of multiple sclerosis in patients who experienced a full-term pregnancy. Eur. Neurol. 2012, 68:150-155.
11. Kim W., Kim S.H., Nakashima I., et al. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 2012, 78:1264-1267.
12. Robb A.O., Mills N.L., Smith I.B., et al. Influence of menstrual cycle on circulating endothelial progenitor cells. Hum. Reprod. 2009, 24:619-625.
13. Lebrun C., Le Page E., Kantarci O., et al. Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult. Scler. 2012, 18:1297-1302.
14. Vukusic S., Hutchinson M., Hours M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004, 127:1353-1360.
15. Pakpoor J., Disanto G., Lacey M.V., et al. Breastfeeding and multiple sclerosis relapses: a meta-analysis. J. Neurol. 2012, 259:2246-2248.
16. Haas J., Hommes O.R. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult. Scler. 2007, 13:900-908.
17. Gulick E.E. Influence of infant feeding method on postpartum relapse of mothers with ms. Int. J. MS Care 2002, 4:4-14.
18. Howie P.W., McNeilly A.S., Houston M.J., Cook A., Boyle H. Effect of supplementary food on suckling patterns and ovarian activity during lactation. Br. Med. J. (Clin. Res. Ed) 1981, 283:757-759.
19. Glasier A., McNeilly A.S., Howie P.W. Pulsatile secretion of LH in relation to the resumption of ovarian activity post partum. Clin. Endocrinol. (Oxf) 1984, 20:415-426.
20. Glasier A., McNeilly A.S., Howie P.W. The prolactin response to suckling. Clin. Endocrinol. (Oxf) 1984, 21:109-116.
21. Langer-Gould A., Gupta R., Huang S., et al. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch. Neurol. 2010, 67:51-57.
22. Hellwig K., Kuge M., Gold R., Langer-Gould A. Exclusive breastfeeding reduces the risk of postpartum relapses-a prospective study from the German ms and pregnancy registry. Neurology 2011, 76:A273.
23. Hellwig K., Kuge M., Gold R., Langer-Gould A. When supplemental infant feedings begin, postpartum multiple sclerosis relapses return. Neurology 2012, 78:P06.186.
24. Hoddinott P., Tappin D., Wright C. Breast feeding. Br. Med. J. 2008, 336:881-887.
25. PRISMS Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 1998, 352:1498-1504.
26. Comi G., Filippi M., Wolinsky J.S. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian glatiramer acetate study group. Ann. Neurol. 2001, 49:290-297.
27. Jacobs L.D., Cookfair D.L., Rudick R.A., et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 1996, 39:285-294.
28. Hollis B.W., Wagner C.L. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis d for both the mother and the nursing infant. Am. J. Clin. Nutr. 2004, 80:1752S-1758S.
29. Hollis B.W., Wagner C.L. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am. J. Clin. Nutr. 2004, 79:717-726.
30. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann. Neurol. 2007, 61:504-513.
31. Tremlett H., van der Mei I., Pittas F., et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008, 31:271-279.
32. Mowry E.M., Krupp L.B., Milazzo M., et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann. Neurol. 2010, 67:618-624.
33. Mowry E., Waubant E., McCulloch C., et al. Higher vitamin D levels are associated with the development of fewer t2-and gadolinium-enhancing brain MRI lesions in multiple sclerosis. Mult. Scler. 2011, 17:S48.
34. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
35. Achiron A., Kishner I., Dolev M., et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J. Neurol. 2004, 251:1133-1137.
36. Bader A.M., Hunt C.O., Datta S., Naulty J.S., Ostheimer G.W. Anesthesia for the obstetric patient with multiple sclerosis. J. Clin. Anesth. 1988, 1:21-24.
37. Ramagopalan S., Yee I., Byrnes J., et al. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry 2012, 83:793-795.
38. Thompson D.S., Nelson L.M., Burns A., Burks J.S., Franklin G.M. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 1986, 36:1097-1099.
39. Weinshenker B.G., Hader W., Carriere W., Baskerville J., Ebers G.C. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 1989, 39:1438-1440.
40. Runmarker B., Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995, 118(Pt 1):253-261.
41. D'Hooghe M.B., Haentjens P., Nagels G., D'Hooghe T., De Keyser J. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J. Neurol. 2012, 259:855-861.
42. D'Hooghe M.B., Nagels G., Uitdehaag B.M. Long-term effects of childbirth in MS. J. Neurol. Neurosurg. Psychiatry 2010, 81:38-41.
43. Brara S.M., Koebnick C., Porter A.H., Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J. Pediatr. 2012, 161:602-607.
44. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol. Today 1993, 14:353-356.
45. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 2005, 170:85-92.
46. McClain M.A., Gatson N.N., Powell N.D., et al. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 2007, 179:8146-8152.
47. Bebo B.F., Dveksler G.S. Evidence that pregnancy specific glycoproteins regulate T-cell function and inflammatory autoimmune disease during pregnancy. Curr. Drug Targets Inflamm. Allergy 2005, 4:231-237.
48. Marin R., Guerra B., Alonso R., Ramirez C.M., Diaz M. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr. Neurovasc. Res. 2005, 2:287-301.
49. Garay L., Deniselle M.C., Lima A., Roig P., De Nicola A.F. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 2007, 107:228-237.
50. Langer-Gould A., Garren H., Slansky A., Ruiz P.J., Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J. Immunol. 2002, 169:1084-1091.
51. Gatson N.N., Williams J.L., Powell N.D., et al. Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J. Neuroimmunol. 2011, 230:105-113.
52. Matthiesen L., Ekerfelt C., Berg G., Ernerudh J. Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy. Am. J. Reprod. Immunol. 1998, 39:362-367.
53. Russell A.S., Johnston C., Chew C., Maksymowych W.P. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J. Rheumatol. 1997, 24:1045-1050.
54. Saito S., Sakai M., Sasaki Y., et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 1999, 117:550-555.
55. Sridama V., Pacini F., Yang S.L., et al. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N. Engl. J. Med. 1982, 307:352-356.
56. Airas L., Saraste M., Rinta S., et al. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin. Exp. Immunol. 2008, 151:235-243.
57. Al-Shammri S., Rawoot P., Azizieh F., et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J. Neurol. Sci. 2004, 222:21-27.
58. Lopez C., Comabella M., Tintore M., Sastre-Garriga J., Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult. Scler. 2006, 12:421-427.
59. Gilmore W., Arias M., Stroud N., et al. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J. Neurol. Sci. 2004, 224:69-76.
60. Neuteboom R.F., Verbraak E., Wierenga-Wolf A.F., et al. Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients. Mult. Scler. 2010, 16:1073-1078.